280 related articles for article (PubMed ID: 27285760)
1. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
[TBL] [Abstract][Full Text] [Related]
2. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
3. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
4. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract][Full Text] [Related]
5. Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.
Chen HY; Lin LT; Wang ML; Tsai KL; Huang PI; Yang YP; Lee YY; Chen YW; Lo WL; Lan YT; Chiou SH; Lin CM; Ma HI; Chen MT
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1850-1861. PubMed ID: 29486283
[TBL] [Abstract][Full Text] [Related]
6. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
[TBL] [Abstract][Full Text] [Related]
7. Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.
Pötschke R; Gielen G; Pietsch T; Kramm C; Klusmann JH; Hüttelmaier S; Kühnöl CD
Pediatr Res; 2020 Mar; 87(4):669-676. PubMed ID: 31756732
[TBL] [Abstract][Full Text] [Related]
8. Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.
Chen HY; Wang ML; Laurent B; Hsu CH; Chen MT; Lin LT; Shen J; Chang WC; Hsu J; Hung MC; Chen YW; Huang PI; Yang YP; Li CP; Ma HI; Chen CH; Lin WC; Chiou SH
Theranostics; 2020; 10(1):201-217. PubMed ID: 31903115
[TBL] [Abstract][Full Text] [Related]
9. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
10. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.
Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H
PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049
[TBL] [Abstract][Full Text] [Related]
12. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis.
Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F
J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072
[TBL] [Abstract][Full Text] [Related]
13. A novel biphenyl diester derivative, AB38b, inhibits glioblastoma cell growth via the ROS-AKT/mTOR pathway.
Meng Q; Zhou J; You F; Wu Y; Yang L; Wang Y; Zhang X; Gao S; Yu R; Yin X
Biochem Pharmacol; 2021 Dec; 194():114795. PubMed ID: 34687671
[TBL] [Abstract][Full Text] [Related]
14. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling.
Jiang K; Yao G; Hu L; Yan Y; Liu J; Shi J; Chang Y; Zhang Y; Liang D; Shen D; Zhang G; Meng S; Piao H
Cell Death Dis; 2020 Apr; 11(4):230. PubMed ID: 32286266
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF
RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859
[TBL] [Abstract][Full Text] [Related]
16. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.
Vo DT; Abdelmohsen K; Martindale JL; Qiao M; Tominaga K; Burton TL; Gelfond JA; Brenner AJ; Patel V; Trageser D; Scheffler B; Gorospe M; Penalva LO
Mol Cancer Res; 2012 Jan; 10(1):143-55. PubMed ID: 22258704
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
19. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
20. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
